NASDAQ:ITCI   Intra-Cellular Therapies Inc.
Estmated Earnings 2-26..

No rising wedges in the yearly chart..

Short interest a bit over 10%..

There is also an inverse H&S pattern but target would put you at top of cup..

Mid Cup is 28.33. Support is often found under mid cup or handle low (HL)

Not a recommendation
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。